Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Constellation Energy Corporation (CEG) vs GeneDx Holdings Corp (WGS) Price & Performance

Constellation Energy CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Constellation Energy Corporation vs GeneDx Holdings Corp — how do they compare? Constellation Energy Corporation trades at $278.92 (market cap $98.63B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Constellation Energy Corporation is far larger — about 40.4× GeneDx Holdings Corp's market cap, and Constellation Energy Corporation pays a 0.61% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

CEGWGS
Market Cap
$98.63B$2.44B
Sector
EnergyTechnology
52-Week High
$403.95$167.51
52-Week Low
$236.50$34.51
Enterprise Value
$122.63B$2.48B
Dividend Yield
0.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Constellation Energy Corporation

CEG trades at $278.68, up 3.05% today, with a bullish technical outlook supported by moving averages and strong analyst sentiment. The company reported Q2 2026 EPS of $2.55, beating estimates, and raised 2026 guidance, driven by nuclear power demand and Calpine integration. Revenue growth is robust, with 2026 projections at $31.3B, and profitability metrics like ROE of 15.26% highlight efficient capital use.

The stock offers upside to the consensus price target of $332.13, with 70% of analysts rating it Buy. Key risks include execution of growth initiatives and market volatility, but strong cash flow and strategic positioning in AI-driven power demand support a positive outlook for investors.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Constellation Energy Corporation

Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.

Read more on CEG

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS